Eva Segelov

30PUBLICATIONS
114CO-AUTHORS
Epidemiological methodsCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsPredictive and prognostic markersCancer cell biology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (30)

|Mar 19, 2026
Target trial emulation: bridging observational studies and randomized trials for health decision-making.

Emilia Riggi, Eva Segelov, Gian Luca Di Tanna

|Jun 16, 2025
The Ave-Rec Trial: Phase II Trial of PDL1/PD1 Blockade with Avelumab after Chemoradiotherapy for Locally Advanced Resectable T3B-4/N1-2 Rectal Cancer.

Michael Michael, Rachel Wong, Sanjeev Gill

|Apr 10, 2025
SRP19 and the protein secretion machinery is a targetable vulnerability in cancers with APC loss.

Xinqi Xi, Ling Liu, Natasha Tuano

|Feb 27, 2025
Assessing Clinical Value of New Treatment Strategies: ESMO-MCBS and ASCO-VF Evaluation in Phase III Trials at ASCO Annual Meeting 2022.

Sofie Seghers, Pablo Mandó, Marc Eid

|Oct 03, 2024
Intersectionality Between Country, Gender and Funding in Authorship for Phase III Trials Presented at the ASCO Annual Meeting 2022.

Laure-Anne Teuwen, Joanna Young, Saleh Alessy

|Aug 08, 2024
Time to Update-Requesting Inclusive Submission Categories for Oncology Research.

Laure-Anne Teuwen, Zain Ahmad, Eva Segelov

Pageof 5

Frequent Collaborators

8 joint publications

Daphne Day

4 joint publications

Kate Webber

4 joint publications

Mike Nguyen

3 joint publications

Amelia McCartney